Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,275.00
-30.00 (-1.30%)
At close: Sep 18, 2026

Biotoxtech Revenue

Biotoxtech had revenue of 14.46B KRW in the quarter ending June 30, 2026, with 50.29% growth. This brings the company's revenue in the last twelve months to 52.48B, up 20.88% year-over-year. In the year 2025, Biotoxtech had annual revenue of 47.02B with 13.73% growth.

Revenue (ttm)
52.48B
Revenue Growth
+20.88%
P/S Ratio
0.68
Revenue / Employee
279.13M
Employees
188
Market Cap
35.76B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.02B5.68B13.73%
Dec 31, 202441.34B8.71B26.69%
Dec 31, 202332.63B-4.66B-12.50%
Dec 31, 202237.29B4.57B13.98%
Dec 31, 202132.72B6.29B23.80%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Nara Mold & Die184.03B
Okong169.03B
BG T&A Co.144.65B
Seoulin Bioscience83.17B
EG Corporation66.55B
CNTUS Co.,Ltd62.50B
Kolmar BioTech40.30B
Catis.23.18B
Revenue Rankings